Inventor · disambiguated record
Jerry Shay
Also filed as: SHAY JERRY · SHAY JERRY W
30 granted patents·15 pending applications·1,046 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
45 records- 0198US5489508ATherapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV TEXAS·Filed 1993·Granted Feb 6, 1996·230 cites·11 claims
- 0291US5695932ATelomerase activity assays for diagnosing pathogenic infectionsUNIV TEXAS·Filed 1993·Granted Dec 9, 1997·55 cites·8 claims
- 0390US6046307AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1997·Granted Apr 4, 2000·75 cites·11 claims
- 0489US6015710AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1996·Granted Jan 18, 2000·78 cites·8 claims
- 0588US8785409B2Compounds having anti-adhesive effects on cancer cellsGRYAZNOV SERGEI M·Filed 2008·Granted Jul 22, 2014·4 cites·23 claims
- 0688US6368789B1Screening methods to identify inhibitors of telomerase activityFiled 1995·Granted Apr 9, 2002·45 cites·54 claims
- 0788US6194206B1Use of oligonucleotide telomerase inhibitors to reduce telomere lengthUNIV TEXAS·Filed 1997·Granted Feb 27, 2001·41 cites·24 claims
- 0884US10463685B2Telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2014·Granted Nov 5, 2019·6 cites·8 claims
- 0984US9732114B2Compounds having anti-adhesive effects on cancer cellsGRYAZNOV SERGEI M·Filed 2014·Granted Aug 15, 2017·2 cites·15 claims
- 1084US5645986ATherapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV TEXAS·Filed 1993·Granted Jul 8, 1997·98 cites·27 claims
- 1183US5707795ATherapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV TEXAS·Filed 1995·Granted Jan 13, 1998·32 cites·33 claims
- 1283US5686245AMethods for screening for agents which modulate telomere lengthUNIV TEXAS·Filed 1995·Granted Nov 11, 1997·32 cites·9 claims
- 1383US5639613AMethods for cancer diagnosis and prognosisUNIV TEXAS·Filed 1995·Granted Jun 17, 1997·92 cites·20 claims
- 1478US6007989AMethods of screening for compounds that derepress or increase telomerase activityUNIV TEXAS·Filed 1997·Granted Dec 28, 1999·53 cites·28 claims
- 1577US6294650B1Inhibition of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1999·Granted Sep 25, 2001·30 cites·13 claims
- 1676US5648215ATelomerase diagnostic methodsUNIV TEXAS·Filed 1994·Granted Jul 15, 1997·46 cites·12 claims
- 1774US5686306AMethods and reagents for lengthening telomeresUNIV TEXAS·Filed 1994·Granted Nov 11, 1997·39 cites·3 claims
- 1873US2024366650A1Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1971US2024009223A16-thio-2'-deoxyguanosine (6-thio-dg) results in telomerase dependent telomere dysfunction and cell death in various models of therapy-resistant cancer cellsUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2069US10082496B2Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesisUNIV TEXAS·Filed 2016·Granted Sep 25, 2018·1 cites·19 claims
- 2169US2024424013A1SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPYUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2266US12070472B2Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2019·Granted Aug 27, 2024·0 cites·8 claims
- 2366US2024115594A1Dinucleotides and their use in treating cancerMAIA BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 2464US5693474AMethods for cancer diagnosis and prognosisUNIV TEXAS·Filed 1995·Granted Dec 2, 1997·26 cites·21 claims
- 2564US2013296405A1Compounds Having Anti-Adhesive Effects on Cancer CellsGERON CORP·Filed 2013·Application pending·0 cites
- 2663US2006172960A1Therapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV TEXAS·Filed 2005·Application pending·0 cites
- 2763US2007010476A1Therapy and diagnosis of conditions related to telomere length and/or telomerase activityWEST MICHAEL D·Filed 2006·Application pending·0 cites
- 2862US6391554B1Detecting cancerous conditions by assaying for telomerase activityGERON CORP AND BOARD OF REGENT·Filed 1999·Granted May 21, 2002·15 cites·5 claims
- 2961US12097213B2Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapyUNIV TEXAS·Filed 2021·Granted Sep 24, 2024·0 cites·16 claims
- 3059US2004198659A1Therapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 3157US2003175766A1Therapy and diagnosis of conditions related to telomere length and/or telomerase activityUNIV TEXAS·Filed 2002·Application pending·0 cites
- 3256US5840495AMethods for diagnosis of conditions associated with elevated levels of telomerase activityUNIV TEXAS·Filed 1995·Granted Nov 24, 1998·5 cites·27 claims
- 3354US5830644AMethod for screening for agents which increase telomerase activity in a cellGERON CORP·Filed 1993·Granted Nov 3, 1998·16 cites·10 claims
- 3451US2021238564A1Telomerase holoenzyme complex and methods of use thereofUNIV TEXAS·Filed 2019·Application pending·0 cites
- 3549US6551774B1Diagnostic methods for conditions associated with elevated cellular levels of telomerase activityUNIV TEXAS·Filed 1999·Granted Apr 22, 2003·9 cites·8 claims
- 3649US6210915B1Telomerase extraction methodUNIV TEXAS SYSTEMS·Filed 1998·Granted Apr 3, 2001·7 cites·15 claims
- 3749US2003190638A1Methods of screening for compounds that derepress or increase telomerase activityUNIV TEXAS·Filed 2002·Application pending·0 cites
- 3849US2021113602A1USE OF 6-THIO-2'-DEOXYGUANOSINE (6-THIO-dG) TO TREAT MELANOMAUNIV TEXAS·Filed 2019·Application pending·0 cites
- 3947US10577344B2Therapeutics targeting truncated adenomatous polyposis coli (APC) proteinsUNIV TEXAS·Filed 2017·Granted Mar 3, 2020·0 cites·31 claims
- 4047US9856233B2Therapeutics targeting truncated adenomatous polyposis coli (APC) proteinsDE BRABANDER JEF·Filed 2014·Granted Jan 2, 2018·0 cites·16 claims
- 4146US5989807ADetecting cancerous conditions by assaying for telomerase activityGERON CORP & BOARD OF REGENTS·Filed 1994·Granted Nov 23, 1999·9 cites·18 claims
- 4245US2019298751A16-thio-2'-deoxyguanosine (6-thio-dg) results in telomerase dependent telomere dysfunction and cell death in various models of therapy-resistant cancer cellsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 4344US2021023107A1USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORSUNIV TEXAS·Filed 2019·Application pending·0 cites
- 4443US2018036331A1Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 4540US10604794B2Method to measure the shortest telomeresUNIV TEXAS·Filed 2018·Granted Mar 31, 2020·0 cites·30 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →